Spero Therapeutics Aktie
0,85
EUR
-0,04
EUR
-4,52
%
0,89
USD
-0,01
USD
-1,55
%
Werbung
Spero Therapeutics Aktie Analyse
09.02.18 | Spero Therapeutics Overweight | Cantor Fitzgerald | |
27.11.17 | Spero Therapeutics Outperform | Oppenheimer & Co. Inc. | |
27.11.17 | Spero Therapeutics Buy | Stifel, Nicolaus & Co., Inc. |
Werbung